TELA Bio (TELA) Total Current Liabilities (2018 - 2026)

TELA Bio has reported Total Current Liabilities for 9 years, with the latest figure at $18.2 million in Q2 2026.

• On a quarterly basis, Total Current Liabilities fell 4.42% year-over-year to $18.2 million in Q2 2026; TTM through Jun 2026 was $18.2 million, a 4.42% decrease from a year earlier, with the FY2025 full-year figure at $18.0 million, up 15.24% from the prior year.
• Total Current Liabilities was $18.2 million for Q2 2026 at TELA Bio, up from $17.8 million in the prior quarter.
• The five-year high for Total Current Liabilities was $19.1 million in Q2 2025, with the low at $11.9 million in Q2 2022.
• Average Total Current Liabilities over 5 years is $15.6 million, with a median of $15.5 million recorded in 2023.
• The sharpest annual moves came in 2022 and 2024: Total Current Liabilities soared 117.91% in 2022, then decreased 8.07% in 2024.
• Over 5 years, Total Current Liabilities stood at $12.4 million in 2022, then jumped by 36.8% to $17.0 million in 2023, then fell by 8.07% to $15.6 million in 2024, then gained by 15.24% to $18.0 million in 2025, then advanced by 1.35% to $18.2 million in 2026.
• The last three Total Current Liabilities figures came in at $18.2 million (Q2 2026), $17.8 million (Q1 2026), and $18.0 million (Q4 2025), per Business Quant data.